Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Reed

Showing results (261-270 of 283) with videos related to

Pageof 29
Sort By:
Diabetologia|February 23, 1999
Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetesM J Reed, K Meszaros, L J Entes, et al.
British Journal of Cancer|January 26, 2000
Modulation of oestrone sulphate formation and hydrolysis in breast cancer cells by breast cyst fluid from British and Hungarian womenA Purohit, B Budai, D Y Wang, et al.
Anticancer Research|March 28, 2001
Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer riskB Budai, I Számel, Z Sulyok, et al.
Cancer Causes & Control : CCC|July 1, 1993
The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom)B L De Stavola, D Y Wang, D S Allen, et al.
Cancer Research|January 1, 1990
Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancerM J Reed, L C Lai, A M Owen, et al.
Journal of Clinical Epidemiology|July 1, 1995
Serum prolactin levels and their relationship to survival in women with operable breast cancerD Y Wang, K A Stepniewska, D S Allen, et al.
Clinical Endocrinology|February 1, 1990
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive casesD S Kiddy, P S Sharp, D M White, et al.
British Journal of Cancer|May 2, 2000
Urinary androgens and breast cancer risk: results from a long-term prospective study based in GuernseyD Y Wang, D S Allen, B L De Stavola, et al.
British Journal of Cancer|October 9, 2008
The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancerM F C Parsons, P A Foster, S K Chander, et al.
British Journal of Cancer|January 22, 2009
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposureJ M Day, P A Foster, H J Tutill, et al.
Pageof 29

Showing results (261-270 of 283) with videos related to

Sort By:
Pageof 29
Diabetologia|February 23, 1999
Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetesM J Reed, K Meszaros, L J Entes, et al.
British Journal of Cancer|January 26, 2000
Modulation of oestrone sulphate formation and hydrolysis in breast cancer cells by breast cyst fluid from British and Hungarian womenA Purohit, B Budai, D Y Wang, et al.
Anticancer Research|March 28, 2001
Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer riskB Budai, I Számel, Z Sulyok, et al.
Cancer Causes & Control : CCC|July 1, 1993
The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom)B L De Stavola, D Y Wang, D S Allen, et al.
Cancer Research|January 1, 1990
Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancerM J Reed, L C Lai, A M Owen, et al.
Journal of Clinical Epidemiology|July 1, 1995
Serum prolactin levels and their relationship to survival in women with operable breast cancerD Y Wang, K A Stepniewska, D S Allen, et al.
Clinical Endocrinology|February 1, 1990
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive casesD S Kiddy, P S Sharp, D M White, et al.
British Journal of Cancer|May 2, 2000
Urinary androgens and breast cancer risk: results from a long-term prospective study based in GuernseyD Y Wang, D S Allen, B L De Stavola, et al.
British Journal of Cancer|October 9, 2008
The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancerM F C Parsons, P A Foster, S K Chander, et al.
British Journal of Cancer|January 22, 2009
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposureJ M Day, P A Foster, H J Tutill, et al.
Pageof 29